Nilotinib differentially affects oligomeric alpha-synuclein and reduces phosphorylated neurofilaments and motor symptoms in Parkinson's disease with dementia and Lewy Body dementia.
Citation: Unpublished 2017/10/03Form of publication: Poster PresentationYear: 2017Conference information: MedStar Washington Hospital Center: MedStar Health Research Symposium, North Bethesda, MD., Fiscal year: FY2018Local accession number: A2017_047Date added to catalog: 2018-08-01Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Poster Presentation | MedStar Authors Catalog | Poster | Available |